CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 4 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-23 | Anderson J. Kermit Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-12-30 | Stilley William B. III Director | Returned to the company | −166,667 | 1,020,979 | ||
| 2022-09-20 | Claiborne Cary J Chief Executive Officer | Grant or award | +75,000 | $0.42 | $32K | 1,100,000 |
| 2022-09-19 | Claiborne Cary J Chief Executive Officer | Grant or award | +25,000 | $0.43 | $11K | 1,025,000 |
| 2022-08-22 | Stilley William B. III Director | Grant or award · Stock Options | +100,000 | 100,000 | ||
| 2022-08-18 | Claiborne Cary J Chief Executive Officer | Grant or award | +1,000,000 | 1,000,000 | ||
| 2022-06-27 | Goodman Tony Director | Grant or award · Stock Option | +25,000 | 25,000 | ||
| 2022-02-23 | Johnson Bankole A. Chief Medical Officer | Grant or award · Employee Stock Option | +35,000 | 35,000 | ||
| 2022-02-23 | Goodman Tony Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2022-02-23 | Truluck Joseph Chief Financial Officer | Grant or award · Employee Stock Option | +100,000 | 100,000 | ||
| 2022-02-23 | Stilley William B. III Chief Executive Officer | Grant or award | +250,000 | 1,187,646 | ||
| 2022-02-23 | Schuyler Kevin Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2022-02-23 | Newman James W. Jr. Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2022-02-23 | Gilliland Robertson H. Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2022-02-23 | Claiborne Cary J Chief Operating Officer | Grant or award · Employee Stock Option | +6,667 | 6,667 | ||
| 2022-02-23 | Anderson J. Kermit Director | Grant or award · Stock Option | +40,000 | 40,000 | ||
| 2021-12-30 | Newman James W. Jr. Director | Purchase | +10,000 | $2.66 | $27K | 20,000 |
| 2021-12-30 | Newman James W. Jr. Director | Purchase | +5,000 | $2.72 | $14K | 50,221 |
| 2021-12-30 | Newman James W. Jr. Director | Purchase | +10,000 | $2.71 | $27K | 34,644 |
| 2021-12-23 | Schuyler Kevin Director | Gift | −312,990 | 0 |
Page 4 of 10 · 190 trades